Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment

Part of paid clinical trials in Notre Dame, Indiana.

Sponsor
University of Notre Dame
Study ID
NCT07342504
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Brief opioid-informed alcohol treatment — BEHAVIORAL
    The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Participants will attend weekly in-person sessions for four weeks.

Study Details

This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.

Key Dates

Start date
Mar 24, 2026
Status verified
Jun 2026
Primary completion
Dec 1, 2026
Completion
Mar 1, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Treatment As Usual
    No intervention is administered. All participants in this study receive prescribed buprenorphine for opioid use disorder and may, related to this, receive behavioral intervention focused on medication adherence and preventing opioid relapse. Treatment As Usual refers to receiving this and no additional intervention.
  • Experimental: Experimental: Brief opioid-informed alcohol treatment
    The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Delivered once per week for 4 weeks.

Primary Outcome Measure

Acceptability of the treatment [ Time Frame: Assessed at Week 4 (end of trial) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Notre DameNotre DameIndiana46556
Beth A Arnold, M.S.
[email protected]
574-213-2096
Ryan Carpenter, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Notre Dame, IN

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
The University of Notre Dame· Notre Dame, IN

Related Studies